Myriad Genetics Inc (MYGN)

Investing Cash Flow

-$3.20M

Quarterly · Period ending: · USD

MYGN logo

MYGN Investing Cash Flow

Latest reported-$3.20M
MYGN Quarterly Cash from Investing (-$4.90M → -$3.20M)
High-resolution chart · PNG

MYGN investing cash flow history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc Investing Cash Flow — Quarterly (USD)
Period endingInvesting Cash Flow (USD)
-3,200,000
-6,500,000
-6,000,000
-6,200,000
-6,900,000
-8,300,000
-5,900,000
7,500,000
-6,400,000
-7,100,000
-12,000,000
-2,500,000
11,800,000
34,600,000
-35,600,000
11,400,000
-12,000,000
-41,300,000
-25,900,000
291,000,000
1,100,000
8,200,000
10,900,000
17,100,000
10,300,000
24,800,000
-7,200,000
-7,100,000
4,500,000
-3,800,000
-8,100,000
-279,000,000
8,900,000
-700,000
-4,600,000
-15,200,000
4,300,000
9,500,000
-2,100,000
-158,000,000
-43,800,000
-16,100,000
-40,500,000
9,000,000
-2,813,000
24,900,000
-8,700,000
27,500,000
-19,861,000
-1,043,000
10,834,000
-8,561,000
-84,629,000
48,081,000
-34,037,000
-5,005,000
-8,174,000
-43,817,000
15,635,000
-2,532,000
-60,938,000
42,480,000
-52,605,000
16,673,000
11,971,000
-13,429,000
-76,522,000
1,312,000
-45,964,000
-17,851,000
-101,161,000
-41,366,000
-19,982,000
20,017,000
-1,325,000
-30,015,000
-58,411,000
6,922,000
1,202,000
3,546,000
-8,086,000
-9,090,000
-54,698,000
-955,000
31,665,000
-5,840,000
639,000
-6,947,000
-7,169,000
8,318,000
513,000
265,000
-17,950,000
1,116,000
-428,000
5,299,000
-2,328,906
12,443,151
7,173,243
20,802,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.